Patents by Inventor Russell E. Baumann

Russell E. Baumann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190276904
    Abstract: The present disclosure provides rapid and non-invasive methods for determining whether a patient will benefit from treatment with therapeutic agents that inhibit Hepatitis C virus (HCV). These methods are based on detecting HCV RNA and/or anti-HCV antibodies in small-volume dried biological fluid samples that are collected using a microsampling device. Kits for use in practicing the methods are also provided.
    Type: Application
    Filed: November 13, 2017
    Publication date: September 12, 2019
    Applicant: Quest Diagnostics Investments LLC
    Inventors: Amy Rogers, John Leake, Nigel J. Clarke, Russell E. Baumann
  • Publication number: 20180136211
    Abstract: The present disclosure provides rapid and non-invasive methods for determining whether a patient will benefit from treatment with therapeutic agents that inhibit Hepatitis C virus (HCV). These methods are based on detecting HCV RNA and/or anti-HCV antibodies in small-volume dried biological fluid samples that are collected using a microsampling device. Kits for use in practicing the methods are also provided.
    Type: Application
    Filed: November 13, 2017
    Publication date: May 17, 2018
    Applicant: Quest Diagnostics Investments LLC
    Inventors: Amy Rogers, John A. Leake, Nigel J. Clarke, Russell E. Baumann